Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
IL-13–programmed airway tuft cells produce PGE2, which promotes CFTR-dependent mucociliary function
Maya E. Kotas, … , Max A. Seibold, Erin D. Gordon
Maya E. Kotas, … , Max A. Seibold, Erin D. Gordon
Published May 24, 2022
Citation Information: JCI Insight. 2022;7(13):e159832. https://doi.org/10.1172/jci.insight.159832.
View: Text | PDF
Research Article Inflammation Pulmonology

IL-13–programmed airway tuft cells produce PGE2, which promotes CFTR-dependent mucociliary function

  • Text
  • PDF
Abstract

Chronic type 2 (T2) inflammatory diseases of the respiratory tract are characterized by mucus overproduction and disordered mucociliary function, which are largely attributed to the effects of IL-13 on common epithelial cell types (mucus secretory and ciliated cells). The role of rare cells in airway T2 inflammation is less clear, though tuft cells have been shown to be critical in the initiation of T2 immunity in the intestine. Using bulk and single-cell RNA sequencing of airway epithelium and mouse modeling, we found that IL-13 expanded and programmed airway tuft cells toward eicosanoid metabolism and that tuft cell deficiency led to a reduction in airway prostaglandin E2 (PGE2) concentration. Allergic airway epithelia bore a signature of PGE2 activation, and PGE2 activation led to cystic fibrosis transmembrane receptor–dependent ion and fluid secretion and accelerated mucociliary transport. These data reveal a role for tuft cells in regulating epithelial mucociliary function in the allergic airway.

Authors

Maya E. Kotas, Camille M. Moore, Jose G. Gurrola II, Steven D. Pletcher, Andrew N. Goldberg, Raquel Alvarez, Sheyla Yamato, Preston E. Bratcher, Ciaran A. Shaughnessy, Pamela L. Zeitlin, Irene H. Zhang, Yingchun Li, Michael T. Montgomery, Keehoon Lee, Emily K. Cope, Richard M. Locksley, Max A. Seibold, Erin D. Gordon

×

Figure 5

PGE2 regulates epithelial CFTR-dependent fluid secretion and mucociliary transport.

Options: View larger image (or click on image) Download as PowerPoint
PGE2 regulates epithelial CFTR-dependent fluid secretion and mucociliary...
(A) Human tracheal epithelial organoids cultured for 21 days in the absence or presence of daily stimulation with 1 μg/mL PGE2, or with PGE2 + EP2 inhibitor (EP2inh) or PGE2 + EP4 inhibitor (EP4inh). Original magnification, 20×; scale bar, 100 μm. representative of at least 2–3 wells per experiment in at least 4 independent experiments with different tracheal and sinus epithelial donors. (B) Diameter of organoids in A. Each dot represents 1 of 200 randomly selected organoids per well × 3 replicate wells per condition. Line indicates median diameter. ****P < 0.0001, ***P < 0.001, *P < 0.05, by 1-way ANOVA with Holm-Šidák correction. (C) Diameter of chronically PGE2-treated organoids as in A and B immediately after acute stimulation with PGE2 ± CFTR inhibitor 172 (CFTRinh). Value ± 95% CI at each time point represents 20 serially imaged organoids per condition. Representative of 2 independent experiments. ****P < 0.0001 by 2-way ANOVA. (D) Short-circuit current measured in human nasal epithelial cells at ALI after inhibition of epithelial sodium channel–dependent current with amiloride, followed by treatment with PGE2 or cAMP activation by forskolin/IBMX, then by CFTR inhibition, and finally by ATP-dependent activation. Donor-normalized quantification of short-circuit currents shown in right panel, with each dot representing treatment of an individual epithelial donor. **P < 0.01 by 2-way ANOVA. (E) Particle transport speed on the surface of tracheal epithelial cells cultured at ALI and stimulated with PGE2 ± CFTR inhibitor 172. Each dot represents 1 tracked particle on the surface of at least 3 replicate wells from each of 3 donors per condition. ****P < 0.0001 by 2-way ANOVA of log-transformed speeds. Line indicates mean.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts